Yes — a life insurance policy owned by an irrevocable life insurance trust (ILIT) can be sold in a life settlement, and the decision belongs to the trustee, who signs the settlement documents on the trust’s behalf; the insured’s signature role is limited because the insured does not own the policy. In fact, for a trustee overseeing an underperforming or purposeless policy, evaluating a sale is not just permitted — it is arguably part of the job.
Courts have found trustees liable in several cases for passively letting trust-owned policies lapse or deteriorate when better options existed (case outcomes vary by state and facts — verify specific precedents with counsel). The fiduciary logic is straightforward: a policy is a trust asset, and a trustee who abandons an asset the market would have paid real money for has some explaining to do to the beneficiaries. Many of these policies were bought for estate tax exposure that no longer exists under the $15 million per-person federal exemption in 2026, which makes the evaluation question urgent for thousands of ILITs.
This guide walks trustees, grantors, and their advisors through the decision framework, the signature and tax mechanics, and a documented process that protects everyone. Pine Lake Life Solutions offers a free policy review — send the policy cover page or call (305) 209-7183.
In This Article
- Why ILIT Policies End Up on the Chopping Block
- The Trustee’s Fiduciary Duty: Evaluate, Don’t Drift
- Who Signs What: The Mechanics of a Trust-Owned Sale
- Taxes: Grantor Trust Status Decides Who Reports the Gain
- Valuing the Policy: Why Many ILIT Policies Price Well
- The Trustee’s Documented Decision Process, Step by Step
- Pitfalls Specific to ILIT Sales
- Frequently Asked Questions
Why ILIT Policies End Up on the Chopping Block
ILITs were the standard vehicle for estate tax planning: the trust owns the policy so the death benefit stays out of the insured’s taxable estate. Three forces now push many of these policies toward re-evaluation:
- The purpose evaporated. With the federal exemption at $15 million per person in 2026 (verify the current indexed figure), estates that drove the original purchase often face no federal estate tax at all — see our full guide on surplus policies after an estate plan change.
- The policy is underperforming. Universal life policies funded on optimistic 1980s–2000s interest assumptions frequently need far larger premiums than illustrated to stay in force.
- The gifts stopped. ILITs depend on annual gifts from the grantor to pay premiums. When the grantor tires of gifting — or passes the checkbook to the next generation — funding pressure forces a decision.
Any one of these justifies a formal review. All three together, which is common, make one overdue.
The Trustee’s Fiduciary Duty: Evaluate, Don’t Drift
A trustee’s core duties — prudence, loyalty, and impartiality among beneficiaries — apply to insurance just as they do to a stock portfolio. Litigation over the past two decades has established that letting a trust-owned policy quietly lapse, or surrendering it without investigating alternatives, can expose a trustee to claims from beneficiaries who later learn the policy had substantial secondary-market value (specific case citations vary by jurisdiction — have trust counsel confirm the precedents relevant to your state).
The protective posture is process: periodically review the policy’s performance and purpose, obtain in-force illustrations, document the analysis, and when an exit is warranted, compare surrender against the settlement market in writing. A trustee who can show a documented, reasoned comparison is in a strong position whatever the decision; a trustee who cannot is exposed in both directions — for keeping a wasting asset or for dumping a valuable one.
Who Signs What: The Mechanics of a Trust-Owned Sale
The settlement paperwork follows ownership, and the trust is the owner:
- The trustee signs the settlement contract, ownership transfer forms, and escrow documents on behalf of the trust. Buyers will require the trust instrument (or a certification of trust) confirming the trustee’s authority to sell trust assets.
- The insured (usually the grantor) cooperates but does not decide. The insured signs HIPAA authorizations so buyers can obtain medical records for life expectancy underwriting, and typically an acknowledgment of the transaction — but the sale decision is the trustee’s.
- Proceeds are paid to the trust, not to the insured or beneficiaries directly. What happens next — distribution, reinvestment, or holding — is governed by the trust’s terms.
If the trust instrument is ambiguous about the power to sell policies, counsel should resolve that before marketing the policy; most modern ILITs grant broad asset-sale powers, but verifying beats assuming.
| Role | Who It Usually Is | What They Sign / Decide in an ILIT Policy Sale |
|---|---|---|
| Owner / seller | The ILIT, acting through its trustee | Trustee decides to sell; signs settlement contract, transfer forms, escrow documents |
| Insured | Usually the grantor (or grantor + spouse for survivorship) | Signs HIPAA authorization and acknowledgments; does not control the sale |
| Beneficiaries | Typically the grantor’s children or descendants | Receive notice as trust/state law requires; proceeds held or distributed per trust terms |
| Trust counsel / tax advisor | Trust’s own professionals | Confirm sale authority, grantor-trust tax treatment, distribution plan |
| Buyer / escrow agent | Licensed settlement provider + independent escrow | Funds escrow before ownership transfer; carrier records the trust’s sale |
Taxes: Grantor Trust Status Decides Who Reports the Gain
The tax mechanics of a sale — proceeds tax-free up to basis, ordinary income up to cash surrender value, capital gain above that — apply to trust-owned policies too. The distinctive question is who reports it. Most ILITs are grantor trusts for income tax purposes, which generally means the grantor, not the trust, reports the gain on their personal return even though the trust receives the cash. Non-grantor trusts report and pay at trust tax rates, which compress to the top bracket quickly.
Grantor-trust status, state trust income tax rules, and the interaction with the trust’s basis in the policy (shaped by how premiums were gifted and paid over decades) make this one of the most technical corners of the transaction. This page is education, not tax advice: no ILIT policy sale should close without the trust’s tax counsel reviewing the projected treatment in writing.
Valuing the Policy: Why Many ILIT Policies Price Well
ILIT policies often fit the settlement market’s sweet spot: large face amounts (frequently $1 million and up), senior insureds in their 70s and 80s, and — for the many ILITs holding guaranteed universal life — no-lapse guarantees that give buyers contractually predictable costs. For general market context, the federal GAO study (GAO-10-775) found sellers typically received about 10% to 35% of face value, roughly 4 to 8 times cash surrender value; large GUL policies with minimal cash value can see an especially wide gap between what surrender returns and what the market pays.
Survivorship (second-to-die) policies, common in ILITs, are sellable too — offers strengthen considerably after the first insured’s death, when the contract prices on a single life. The inputs a trustee needs for a market check are modest: the policy cover page to start, then an in-force illustration and, with the insured’s HIPAA authorization, medical records. See what policies qualify.
The Trustee’s Documented Decision Process, Step by Step
A defensible process looks like this:
- 1. Confirm authority. Counsel verifies the trust instrument permits selling policies and identifies any consent requirements.
- 2. Establish the facts. Obtain the current statement and an in-force illustration; project premiums required to maintain the policy and the trust’s capacity to fund them.
- 3. Re-examine the purpose with the grantor’s estate counsel: federal and state estate tax exposure, equalization goals, liquidity needs.
- 4. Get market bids. A free settlement review establishes what buyers would pay; obtain offers in writing with commissions disclosed.
- 5. Compare in writing. Keep vs. reduce vs. surrender vs. sell, after tax — see the settlement-vs-surrender framework and how surrender value works.
- 6. Communicate with beneficiaries as the trust and state law require, and document the decision in a trustee resolution.
Steps 4 and 5 are where Pine Lake can help at no cost; the rest belong to the trust’s own advisors.
Pitfalls Specific to ILIT Sales
A few traps recur in trust-owned transactions:
- Escrow discipline. As with any settlement, ownership should transfer only when funds are secured with an independent escrow agent — a fiduciary has even less excuse for sloppy closing mechanics than an individual seller.
- Conflicted advice. If the person recommending against a sale earns commissions on keeping or replacing the policy — or the person recommending a sale earns an undisclosed spread — the trustee should get the economics of every recommendation in writing.
- Distribution timing. Proceeds landing in the trust raise their own questions — distribute now, hold, or reinvest — with income tax and beneficiary-fairness consequences the trust’s counsel should settle before closing, not after.
- The insured’s benefits. If the grantor-insured is on or near Medicaid, distributions traced to them can affect eligibility; sequence with an elder law attorney.
None of these are reasons not to sell; all are reasons to run the process formally. For the transaction arc itself, see how the process works, and start with a free review by sending the policy cover page or calling (305) 209-7183. Pine Lake Life Solutions works alongside the trust’s own counsel — never in place of it.
Frequently Asked Questions
Can a trustee sell a life insurance policy owned by an ILIT?
Yes, provided the trust instrument grants the power to sell trust assets, which most modern ILITs do. The trustee makes the decision and signs the settlement documents on the trust’s behalf; the insured cooperates with medical releases but does not control the sale. Counsel should confirm authority before the policy is marketed.
Is a trustee required to consider selling an underperforming policy?
A trustee’s duty of prudence requires managing trust assets actively, and courts have found trustees liable for passively letting trust-owned policies lapse or deteriorate when alternatives existed. Documented periodic review — and a written comparison of keep, surrender, and sell when an exit is warranted — is the protective standard.
Who pays tax on the gain when an ILIT sells a policy?
It depends on the trust’s income tax status. Most ILITs are grantor trusts, meaning the grantor generally reports the gain personally even though the trust receives the proceeds. Non-grantor trusts report at compressed trust tax rates. This is technical enough that no sale should close without the trust’s tax counsel confirming the treatment.
The ILIT was created to pay estate taxes we no longer owe. Is that a reason to sell?
It is the classic reason. With the 2026 federal exemption at $15 million per person, many estates that drove ILIT purchases face no federal estate tax. Confirm there is no remaining purpose — state estate taxes, equalization, business liquidity — and if the policy is truly surplus, compare a settlement against surrender with real numbers.
The grantor is tired of making annual gifts to fund premiums. What are the options?
The trustee can evaluate reducing the face amount, converting to reduced paid-up coverage, surrendering, or selling the policy. Letting it lapse is the one option that should be off the table until the others are priced — a lapse returns nothing, while a qualifying policy may sell for several times its surrender value.
Can a survivorship policy inside an ILIT be sold?
Yes. While both insureds are living, long joint life expectancy tempers pricing; after the first death, the policy prices on a single life and offers often improve substantially. A widowed survivor’s ILIT holding a survivorship policy with no estate tax purpose is a notably strong candidate.
Do the beneficiaries have to approve the sale?
Usually the decision is the trustee’s alone under the trust’s powers, but notice or consent requirements vary by trust instrument and state law. Even where consent is not required, informing beneficiaries and documenting the reasoning is good fiduciary hygiene and reduces later disputes.
What does it cost to find out what the trust’s policy is worth?
Nothing. A free review starts with the policy cover page; from there an in-force illustration and the insured’s HIPAA authorization allow real written offers. The trustee can then run the documented comparison with the trust’s own advisors, with no obligation to transact.
Find out what your policy is worth — free, confidential, no obligation.
A 15-minute educational review covers your eligibility, every alternative, and a realistic view of what each path would net you.
Related Reading
- Estate Plan Changed
- Life Settlement Vs Surrender
- What Policies Qualify For Life Settlement
- Cash Surrender Value Life Insurance
- How It Works Policy Options
- No Beneficiaries Left
Pine Lake Life Solutions does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.